The Kern Pharma Team takes a risk in La Vuelta
Rarely could a great cycling tour be as decisive for the future of a cycling team as it can be. The Return for Kern Pharmaafter last March the Catalan pharmaceutical company announced that it was closing the seven-year cycle of sponsorship with the Navarrese team. Since then, uncertainty has hovered within the team. Several of its riders have already secured tomorrow in other squads and, for now, it remains unannounced if any brand or company is interested in sponsoring the team.
In the middle of this tense wait, the still Kern Pharma has announced the team with which they go to The Return. The eight chosen cyclists are Urko Berrade, Marc Bustrenga, Iván Cobo, Iñigo Elosegui, Ibon Ruiz, Iván Sosa, Diego Uriarte and Mats Wenzel.
In the memory of good cycling fans, the three stage victories achieved in 2024, in which they also finished as the ninth best team of the 22 participants, considering that the Kern Pharma It is a UCI Pro Team category team and was measured a priori against formations of much higher quality, as indicated by its condition.and World Tour.
25 are the cyclists that make up the team Kern Pharma this season and so far the team has achieved six victories: two of Ivan Coboand the rest of Marc Bustrenga, Mats Wenzel, Iván Ramiro Sosa and Ibon Ruiz. A good performance by the eight chosen for the Spanish round should open a door to hope for the team’s continuity in the peloton from January 1, 2027.
“We promise our maximum effort and commitment to the fans. We continue to dream big because we believe in ourselves and what we do, and the Vuelta a España is a great opportunity to show it to everyone,” he says. Juanjo Oroz, general manager of the Kern Pharma Team.
